Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Assessment of Long Term Outcomes on Entecavir
Clinical Trial Protocol ID
06121102

Clinical Trial Investigator Name
S. Martin Cohen, MD

Clinical Trial Title

Observational Assessment of Long Term Outcomes on Entecavir



Clinical Trial Protocol Description

This is a study to assess the rates of the following clinical outcomes:

  1. Malignant neoplasms (overall and non-HCC, in each case including carcinoma in situ [CIS] but excluding non-melanoma skin cancer, and HCC).
  2. Liver-related events of HBV disease progression.
  3. Mortality (all cause, liver-related).


Clinical Trial Eligibility Criteria

You may be eligible for this study if you have:

  • Chronic HBV infection
  • HBV nucleoside/tide-naïve or –experienced
  • No prior treatment with ETV (entecavir)

For more information, please call the number below.





Contact Name Doris Yadav, RN, BS Senior Research Coordinator
Contact Phone (312) 563-3919
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Hepatology Trials
Assessment of Long Term Outcomes on Entecavir

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois